98%
921
2 minutes
20
Aims: This study sought to evaluate the feasibility, accuracy, and diagnostic performance of a fully automated deep learning model for assessing left ventricular diastolic function (LVDF) using 2D transthoracic echocardiography (TTE).
Methods And Results: In this prospective observational study, 302 patients underwent 2D TTE for suspected diastolic dysfunction. Diastolic parameters, such as mitral inflow velocities, tissue Doppler indices, left atrial volumes, and tricuspid regurgitation velocity, were automatically analyzed using AI-based software (Ligence Heart) and compared with expert manual measurements. The AI achieved a maximal measurement success rate for spectral and tissue Doppler parameters. Strong correlation was observed for key variables such as E velocity (r = 0.93), A velocity (r = 0.88), E/A ratio (r = 0.94), and LAVi (r = 0.92), while lower agreement was noted for TR velocity. Classification of diastolic dysfunction showed high accuracy in identifying normal and severe grades, with more variability in intermediate categories. No consistent bias or directional error was observed across measured parameters.
Conclusion: Automated AI-based evaluation of diastolic function using 2D TTE is feasible and provides accurate, guideline-based measurements with strong correlation to expert interpretation. The software demonstrated promising results in classifying LVDF grades, particularly in distinguishing normal and severe dysfunction. This approach shows potential to enhance diagnostic consistency and efficiency in clinical practice, although further validation is needed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/echo.70290 | DOI Listing |
Clin J Am Soc Nephrol
September 2025
University College London Great Ormond Street Hospital for Children and Institute of Child Health, London, UK.
Background: Experience with icodextrin use in children on long-term peritoneal dialysis is limited. We describe international icodextrin prescription practices and their impact on clinical outcomes: ultrafiltration, blood pressure control, residual kidney function (RKF), technique and patient survival.
Methods: We included patients under 21 years enrolled in the International Pediatric Peritoneal Dialysis Network (IPPN) between 2007 and 2024, on automated PD with a daytime dwell.
J Thromb Thrombolysis
September 2025
Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.
In this review, we aimed to evaluate Sonothrombolysis when combined with primary percutaneous coronary intervention (pPCI) in STEMI patients with regard to improving cardiac function and clinical outcomes. This study primarily assesses short-term efficacy outcomes, while long-term impacts, such as mortality, were not evaluated. Following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines, we searched four electronic databases (PubMed, Scopus, Cochrane Library, and Web of Science) to identify eligible studies reported up to November 2024.
View Article and Find Full Text PDFEur J Heart Fail
September 2025
Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital Dallas, Dallas, TX, USA.
Aims: Obesity is commonly hypothesized to lead to the development of heart failure (HF) in part due to increases in blood volume (BV) and left ventricular (LV) remodelling. Whether adiposity and obesity severity are associated with BV expansion and subsequent LV remodelling in middle-aged individuals at increased risk (IR) prior to the onset of HF is unknown.
Methods And Results: We analysed data from 96 middle-aged (40-64 years) non-obese (25.
ESC Heart Fail
September 2025
Department of Cardiac-, Thoracic-, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
Aims: Non-pharmacological therapies for acute decompensated heart failure (HF) and cardiogenic shock have evolved considerably in recent decades. Short-term mechanical circulatory support (MCS) devices can be used as circulatory backup. While nearly all available devices use continuous flow, evidence indicates that pulsatile flow can be more effective.
View Article and Find Full Text PDFBr J Nutr
September 2025
Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Although numerous clinical studies suggest that ginseng supplementation may benefit cardiovascular disease (CVD) risk factors, results remain inconclusive. This systematic review and meta-analysis evaluated the effects of ginseng supplementation on CVD-related risk factors. Relevant studies were identified through electronic searches in Embase, Web of Science, Scopus, PubMed, and CENTRAL up to August 2024.
View Article and Find Full Text PDF